Ronen Eliahu Mukamel, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Minisatellite Repeats | 2 | 2023 | 163 | 1.560 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2023 | 48 | 0.860 |
Why?
|
| Calcium Channels | 1 | 2023 | 620 | 0.660 |
Why?
|
| Polymorphism, Genetic | 2 | 2023 | 4243 | 0.470 |
Why?
|
| Genome, Human | 5 | 2024 | 4423 | 0.460 |
Why?
|
| Glaucoma | 1 | 2023 | 1186 | 0.440 |
Why?
|
| Phenotype | 6 | 2024 | 16575 | 0.290 |
Why?
|
| Body Height | 2 | 2022 | 1566 | 0.250 |
Why?
|
| DNA Copy Number Variations | 3 | 2024 | 2024 | 0.250 |
Why?
|
| Agouti Signaling Protein | 1 | 2024 | 23 | 0.240 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 6919 | 0.220 |
Why?
|
| Retroelements | 1 | 2024 | 162 | 0.210 |
Why?
|
| Antley-Bixler Syndrome Phenotype | 1 | 2022 | 3 | 0.210 |
Why?
|
| Skin Pigmentation | 1 | 2024 | 277 | 0.200 |
Why?
|
| Polynucleotide Adenylyltransferase | 1 | 2021 | 12 | 0.200 |
Why?
|
| Aggrecans | 1 | 2021 | 89 | 0.190 |
Why?
|
| Intermediate Filament Proteins | 1 | 2021 | 262 | 0.180 |
Why?
|
| Haplotypes | 2 | 2022 | 2715 | 0.160 |
Why?
|
| Hair | 1 | 2021 | 498 | 0.150 |
Why?
|
| Gene Frequency | 2 | 2022 | 3603 | 0.150 |
Why?
|
| Mosaicism | 1 | 2021 | 477 | 0.140 |
Why?
|
| Chromosome Mapping | 2 | 2022 | 4612 | 0.140 |
Why?
|
| Mucin-1 | 1 | 2021 | 538 | 0.140 |
Why?
|
| Lipoprotein(a) | 1 | 2021 | 482 | 0.140 |
Why?
|
| Antigens | 1 | 2021 | 1441 | 0.130 |
Why?
|
| Genetic Association Studies | 2 | 2024 | 2731 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2022 | 15920 | 0.130 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 780 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2022 | 2113 | 0.120 |
Why?
|
| Multifactorial Inheritance | 1 | 2022 | 1387 | 0.120 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2022 | 918 | 0.110 |
Why?
|
| Cystic Fibrosis | 1 | 2022 | 1283 | 0.100 |
Why?
|
| Linkage Disequilibrium | 2 | 2022 | 1994 | 0.070 |
Why?
|
| Proteins | 1 | 2021 | 5993 | 0.070 |
Why?
|
| Kidney | 1 | 2021 | 7033 | 0.060 |
Why?
|
| Alleles | 2 | 2024 | 6857 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2024 | 657 | 0.050 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2021 | 43 | 0.050 |
Why?
|
| Introns | 1 | 2024 | 968 | 0.050 |
Why?
|
| Penetrance | 1 | 2022 | 382 | 0.040 |
Why?
|
| Tissue Banks | 1 | 2021 | 184 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 12159 | 0.040 |
Why?
|
| Sample Size | 1 | 2022 | 843 | 0.040 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2022 | 260 | 0.040 |
Why?
|
| Exons | 1 | 2024 | 2380 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2021 | 959 | 0.040 |
Why?
|
| Humans | 9 | 2024 | 761208 | 0.030 |
Why?
|
| Autopsy | 1 | 2021 | 1010 | 0.030 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2021 | 600 | 0.030 |
Why?
|
| Europe | 1 | 2022 | 3423 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2021 | 2599 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 12676 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 1852 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2021 | 3430 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 17897 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2022 | 7966 | 0.020 |
Why?
|
| Genotype | 1 | 2021 | 12985 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2021 | 8479 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2024 | 5809 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2021 | 7851 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 24021 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41496 | 0.010 |
Why?
|
| Child | 1 | 2021 | 80152 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 221119 | 0.000 |
Why?
|